HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-JAN-19 6NSP TITLE TRK-A IN COMPLEX WITH LIGAND 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 6 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 7 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 8 P140-TRKA; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TRK-A KINASE DOMAIN HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR KEYWDS 2 INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.SUBRAMANIAN,D.G.BROWN REVDAT 3 13-MAR-24 6NSP 1 REMARK REVDAT 2 10-JUL-19 6NSP 1 JRNL REVDAT 1 22-MAY-19 6NSP 0 JRNL AUTH G.SUBRAMANIAN,P.D.JOHNSON,T.ZACHARY,N.ROUSH,Y.ZHU,S.J.BOWEN, JRNL AUTH 2 A.JANSSEN,B.A.DUCLOS,T.WILLIAMS,C.JAVENS,N.D.SHALALY, JRNL AUTH 3 D.M.MOLINA,A.J.WITTWER,J.L.HIRSCH JRNL TITL DECIPHERING THE ALLOSTERIC BINDING MECHANISM OF THE HUMAN JRNL TITL 2 TROPOMYOSIN RECEPTOR KINASE A ( HTRKA) INHIBITORS. JRNL REF ACS CHEM.BIOL. V. 14 1205 2019 JRNL REFN ESSN 1554-8937 JRNL PMID 31059222 JRNL DOI 10.1021/ACSCHEMBIO.9B00126 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 14583 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1213 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1017 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2339 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.21000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : -0.69000 REMARK 3 B12 (A**2) : 0.11000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.312 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.247 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.182 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.145 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2431 ; 0.013 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2242 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3300 ; 1.898 ; 1.636 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5163 ; 1.370 ; 1.571 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 296 ; 7.356 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 134 ;32.394 ;20.597 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;17.440 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;20.989 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 293 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2761 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 559 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1184 ; 3.411 ; 4.329 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1182 ; 3.388 ; 4.323 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1480 ; 5.235 ; 6.478 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1480 ; 5.224 ; 6.477 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1245 ; 4.039 ; 4.769 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1245 ; 4.039 ; 4.769 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1820 ; 6.372 ; 6.942 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2677 ; 8.700 ;49.116 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2670 ; 8.688 ;49.060 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 500 A 801 REMARK 3 ORIGIN FOR THE GROUP (A): 13.6868 4.7418 19.6828 REMARK 3 T TENSOR REMARK 3 T11: 0.1366 T22: 0.0199 REMARK 3 T33: 0.0400 T12: 0.0463 REMARK 3 T13: 0.0219 T23: 0.0086 REMARK 3 L TENSOR REMARK 3 L11: 0.2283 L22: 1.3589 REMARK 3 L33: 0.6065 L12: 0.0843 REMARK 3 L13: -0.3020 L23: -0.4705 REMARK 3 S TENSOR REMARK 3 S11: -0.0853 S12: -0.0540 S13: -0.0165 REMARK 3 S21: 0.0911 S22: 0.0308 S23: -0.0747 REMARK 3 S31: -0.0033 S32: 0.0413 S33: 0.0545 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6NSP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000239348. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15796 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 76.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.4500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M KH2PO4/ 0.1M NAH2PO4/ 0.1M REMARK 280 MES/NAOH PH 6.0 AND 1.9M NACL (CRYO: 25% GLYCEROL IN RESERVOIR), REMARK 280 OR 18% (W/V) PEG 3350, 0.2M CACL2, 0.1M, MES PH = 6.50 (CRYO: REMARK 280 DIRECT)., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.05433 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 152.10867 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 152.10867 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 76.05433 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 609 REMARK 465 LEU A 610 REMARK 465 LEU A 611 REMARK 465 GLY A 796 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 559 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 562 CD OE1 OE2 REMARK 480 LEU A 563 CG CD1 CD2 REMARK 480 GLN A 570 CD OE1 NE2 REMARK 480 ARG A 686 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 747 CD OE1 OE2 REMARK 480 LYS A 775 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 547 -71.80 -68.17 REMARK 500 GLU A 548 -172.17 -64.76 REMARK 500 ALA A 549 32.29 -159.44 REMARK 500 ARG A 583 150.86 -49.86 REMARK 500 ARG A 649 -17.32 84.66 REMARK 500 VAL A 683 -75.93 -103.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG A 559 11.30 REMARK 500 ARG A 559 11.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L0P A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6NPT RELATED DB: PDB DBREF 6NSP A 500 796 UNP P04629 NTRK1_HUMAN 402 698 SEQRES 1 A 297 ALA CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU SEQRES 2 A 297 LYS TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE SEQRES 3 A 297 LEU ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS SEQRES 4 A 297 MET LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SEQRES 5 A 297 SER ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU SEQRES 6 A 297 THR MET LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY SEQRES 7 A 297 VAL CYS THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU SEQRES 8 A 297 TYR MET ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER SEQRES 9 A 297 HIS GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP SEQRES 10 A 297 VAL ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA SEQRES 11 A 297 VAL ALA SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA SEQRES 12 A 297 GLY LEU HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN SEQRES 13 A 297 CYS LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP SEQRES 14 A 297 PHE GLY MET SER ARG ASP ILE TYR SER THR ASP TYR TYR SEQRES 15 A 297 ARG VAL GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET SEQRES 16 A 297 PRO PRO GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SEQRES 17 A 297 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE SEQRES 18 A 297 PHE THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN SEQRES 19 A 297 THR GLU ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU SEQRES 20 A 297 GLU ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE SEQRES 21 A 297 MET ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SEQRES 22 A 297 SER ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA SEQRES 23 A 297 GLN ALA PRO PRO VAL TYR LEU ASP VAL LEU GLY HET L0P A 801 31 HETNAM L0P N-(8-METHYL-2-PHENYLIMIDAZO[1,2-A]PYRIDIN-3-YL)-2-(3- HETNAM 2 L0P OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL)ACETAMIDE FORMUL 2 L0P C24 H20 N4 O2 S FORMUL 3 HOH *46(H2 O) HELIX 1 AA1 LYS A 506 ARG A 508 5 3 HELIX 2 AA2 SER A 550 LEU A 567 1 18 HELIX 3 AA3 ASP A 596 SER A 603 1 8 HELIX 4 AA4 GLY A 623 LEU A 644 1 22 HELIX 5 AA5 ALA A 652 ARG A 654 5 3 HELIX 6 AA6 MET A 671 TYR A 676 1 6 HELIX 7 AA7 SER A 677 TYR A 680 5 4 HELIX 8 AA8 PRO A 690 MET A 694 5 5 HELIX 9 AA9 PRO A 695 ARG A 702 1 8 HELIX 10 AB1 THR A 705 THR A 722 1 18 HELIX 11 AB2 SER A 732 GLN A 742 1 11 HELIX 12 AB3 PRO A 753 TRP A 764 1 12 HELIX 13 AB4 GLU A 767 ARG A 771 5 5 HELIX 14 AB5 SER A 773 ALA A 787 1 15 HELIX 15 AB6 PRO A 788 VAL A 794 1 7 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 GLY A 522 HIS A 530 -1 O LEU A 526 N TRP A 514 SHEET 3 AA1 5 LYS A 538 LEU A 546 -1 O VAL A 543 N PHE A 525 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 VAL A 658 0 SHEET 2 AA2 2 VAL A 664 ILE A 666 -1 O LYS A 665 N LEU A 657 SHEET 1 AA3 2 TYR A 681 ARG A 682 0 SHEET 2 AA3 2 MET A 688 LEU A 689 -1 O LEU A 689 N TYR A 681 CISPEP 1 ARG A 583 PRO A 584 0 2.12 SITE 1 AC1 9 GLU A 560 LEU A 564 LEU A 567 MET A 587 SITE 2 AC1 9 PHE A 589 GLY A 667 ASP A 668 GLY A 670 SITE 3 AC1 9 ARG A 673 CRYST1 51.994 51.994 228.163 90.00 90.00 120.00 P 31 1 2 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019233 0.011104 0.000000 0.00000 SCALE2 0.000000 0.022208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004383 0.00000